Form 4: Nevro Corp Executive Kashif Rashid Reports Stock Award and Tax Withholding

General Counsel Kashif Rashid of Nevro Corp reports acquisition of restricted stock units and disposition of shares for tax withholding.

Summary

• On March 7, 2024, Kashif Rashid, General Counsel of Nevro Corp, reported the acquisition of 84,326 shares of common stock as restricted stock units (RSUs).
• These RSUs vest over time, with one-third vesting on March 7, 2025, and the remainder vesting quarterly thereafter, fully vested by the third anniversary of the grant date, contingent upon continued service.
• Rashid also reported the disposition of 7,045 shares of common stock on the same date to cover tax obligations at a price of $15.32 per share.
• Following these transactions, Rashid beneficially owns 166,462 shares of Nevro Corp, including 124,629 RSUs.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine disclosure of stock transactions. The acquisition of RSUs is a positive sign, but the sale of shares for tax obligations is a neutral event.

Positives

• The acquisition of RSUs indicates confidence in the company's future performance from a key executive.

Negatives

• The sale of shares to cover tax obligations, while common, can be perceived negatively if the amount is substantial.

Risks

• The vesting of RSUs is contingent upon continued service, creating a potential risk if the executive leaves the company before full vesting.

Future Outlook

The document does not contain specific forward-looking statements, but the vesting schedule of the RSUs implies a multi-year commitment from the executive.

Industry Context

Form 4 filings are routine disclosures for publicly traded companies and their insiders. They provide transparency into the trading activities of company executives and directors, which can be informative for investors.

Comparison to Industry Standards

• Stock-based compensation, including RSUs, is a common practice among publicly traded companies, especially in the technology and healthcare sectors, to incentivize and retain key employees.
• The vesting schedule of the RSUs (one-third after one year, then quarterly) is a fairly standard vesting arrangement.
• Comparable companies such as Medtronic, Boston Scientific, and Abbott also utilize stock-based compensation as part of their executive compensation packages.

Stakeholder Impact

• The transactions have a minor impact on shareholders, as they reflect standard executive compensation practices.
• Employees may view the RSU grants as a positive sign of the company's commitment to its employees.

Key Dates